649 related articles for article (PubMed ID: 25820374)
1. Prevalence of HPV infection in head and neck carcinomas shows geographical variability: a comparative study from Brazil and Germany.
Hauck F; Oliveira-Silva M; Dreyer JH; Perrusi VJ; Arcuri RA; Hassan R; Bonvicino CR; Barros MH; Niedobitek G
Virchows Arch; 2015 Jun; 466(6):685-93. PubMed ID: 25820374
[TBL] [Abstract][Full Text] [Related]
2. Detection of transcriptionally active high-risk HPV in patients with head and neck squamous cell carcinoma as visualized by a novel E6/E7 mRNA in situ hybridization method.
Bishop JA; Ma XJ; Wang H; Luo Y; Illei PB; Begum S; Taube JM; Koch WM; Westra WH
Am J Surg Pathol; 2012 Dec; 36(12):1874-82. PubMed ID: 23060353
[TBL] [Abstract][Full Text] [Related]
3. Low prevalence of p16-positive HPV-related head-neck cancers in Thailand: tertiary referral center experience.
Nopmaneepaisarn T; Tangjaturonrasme N; Rawangban W; Vinayanuwattikun C; Keelawat S; Bychkov A
BMC Cancer; 2019 Nov; 19(1):1050. PubMed ID: 31694600
[TBL] [Abstract][Full Text] [Related]
4. P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias.
Mooren JJ; Gültekin SE; Straetmans JM; Haesevoets A; Peutz-Kootstra CJ; Huebbers CU; Dienes HP; Wieland U; Ramaekers FC; Kremer B; Speel EJ; Klussmann JP
Int J Cancer; 2014 May; 134(9):2108-17. PubMed ID: 24127203
[TBL] [Abstract][Full Text] [Related]
5. The role of human papillomavirus in p16-positive oral cancers.
Belobrov S; Cornall AM; Young RJ; Koo K; Angel C; Wiesenfeld D; Rischin D; Garland SM; McCullough M
J Oral Pathol Med; 2018 Jan; 47(1):18-24. PubMed ID: 29024035
[TBL] [Abstract][Full Text] [Related]
6. A systematic investigation of the association between HPV and the clinicopathological parameters and prognosis of oral and oropharyngeal squamous cell carcinomas.
Wang F; Zhang H; Xue Y; Wen J; Zhou J; Yang X; Wei J
Cancer Med; 2017 May; 6(5):910-917. PubMed ID: 28378539
[TBL] [Abstract][Full Text] [Related]
7. RNA in-situ hybridization is a practical and effective method for determining HPV status of oropharyngeal squamous cell carcinoma including discordant cases that are p16 positive by immunohistochemistry but HPV negative by DNA in-situ hybridization.
Rooper LM; Gandhi M; Bishop JA; Westra WH
Oral Oncol; 2016 Apr; 55():11-6. PubMed ID: 27016012
[TBL] [Abstract][Full Text] [Related]
8. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus co-infection and survival in oral and oropharyngeal squamous cell carcinoma: A study in 235 Brazilian patients.
Silveira HA; Almeida LY; Carlos R; Silva EV; Ferrisse TM; Duarte A; Cardoso SCS; Polanco XBJ; Bufalino A; Ribeiro-Silva A; León JE
Auris Nasus Larynx; 2022 Apr; 49(2):258-270. PubMed ID: 34274177
[TBL] [Abstract][Full Text] [Related]
10. The utility of high-risk human papillomavirus in situ hybridization in cytology cell block material from cystic head and neck lesions.
Han LM; Saunders TA; Calkins SM
Cancer Cytopathol; 2022 Feb; 130(2):154-160. PubMed ID: 34758205
[TBL] [Abstract][Full Text] [Related]
11. A comprehensive evaluation of human papillomavirus positive status and p16INK4a overexpression as a prognostic biomarker in head and neck squamous cell carcinoma.
Deng Z; Hasegawa M; Aoki K; Matayoshi S; Kiyuna A; Yamashita Y; Uehara T; Agena S; Maeda H; Xie M; Suzuki M
Int J Oncol; 2014 Jul; 45(1):67-76. PubMed ID: 24820457
[TBL] [Abstract][Full Text] [Related]
12. Detection of human papillomavirus type 16 in oropharyngeal squamous cell carcinoma using droplet digital polymerase chain reaction.
Biron VL; Kostiuk M; Isaac A; Puttagunta L; O'Connell DA; Harris J; Côté DW; Seikaly H
Cancer; 2016 May; 122(10):1544-51. PubMed ID: 26989832
[TBL] [Abstract][Full Text] [Related]
13. Performance of a Branch Chain RNA In Situ Hybridization Assay for the Detection of High-risk Human Papillomavirus in Head and Neck Squamous Cell Carcinoma.
Kerr DA; Arora KS; Mahadevan KK; Hornick JL; Krane JF; Rivera MN; Ting DT; Deshpande V; Faquin WC
Am J Surg Pathol; 2015 Dec; 39(12):1643-52. PubMed ID: 26426378
[TBL] [Abstract][Full Text] [Related]
14. Oropharyngeal squamous cell carcinoma: p16/p53 immunohistochemistry as a strong predictor of HPV tumour status.
Benzerdjeb N; Tantot J; Blanchet C; Philouze P; Mekki Y; Lopez J; Devouassoux-Shisheboran M
Histopathology; 2021 Sep; 79(3):381-390. PubMed ID: 33560536
[TBL] [Abstract][Full Text] [Related]
15. Nonuniform Distribution of High-risk Human Papillomavirus in Squamous Cell Carcinomas of the Oropharynx: Rethinking the Anatomic Boundaries of Oral and Oropharyngeal Carcinoma From an Oncologic HPV Perspective.
Gelwan E; Malm IJ; Khararjian A; Fakhry C; Bishop JA; Westra WH
Am J Surg Pathol; 2017 Dec; 41(12):1722-1728. PubMed ID: 28877058
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers of HPV in head and neck squamous cell carcinoma.
Liang C; Marsit CJ; McClean MD; Nelson HH; Christensen BC; Haddad RI; Clark JR; Wein RO; Grillone GA; Houseman EA; Halec G; Waterboer T; Pawlita M; Krane JF; Kelsey KT
Cancer Res; 2012 Oct; 72(19):5004-13. PubMed ID: 22991304
[TBL] [Abstract][Full Text] [Related]
17. Histologic Typing in Oropharyngeal Squamous Cell Carcinoma: A 4-Year Prospective Practice Study With p16 and High-Risk HPV mRNA Testing Correlation.
Gondim DD; Haynes W; Wang X; Chernock RD; El-Mofty SK; Lewis JS
Am J Surg Pathol; 2016 Aug; 40(8):1117-24. PubMed ID: 27035614
[TBL] [Abstract][Full Text] [Related]
18. Discrepancy in p16 expression in patients with HPV-associated head and neck squamous cell carcinoma in Thailand: clinical characteristics and survival outcomes.
Arsa L; Siripoon T; Trachu N; Foyhirun S; Pangpunyakulchai D; Sanpapant S; Jinawath N; Pattaranutaporn P; Jinawath A; Ngamphaiboon N
BMC Cancer; 2021 May; 21(1):504. PubMed ID: 33957888
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity of p16 immunohistochemistry and increased sensitivity of RNA in situ hybridization in cytology specimens of HPV-related head and neck squamous cell carcinoma.
Wong KS; Krane JF; Jo VY
Cancer Cytopathol; 2019 Oct; 127(10):632-642. PubMed ID: 31509355
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus (HPV) 16 and the prognosis of head and neck cancer in a geographical region with a low prevalence of HPV infection.
López RV; Levi JE; Eluf-Neto J; Koifman RJ; Koifman S; Curado MP; Michaluart-Junior P; Figueiredo DL; Saggioro FP; de Carvalho MB; Kowalski LP; Abrahão M; de Góis-Filho F; Tajara EH; Waterboer T; Boffetta P; Brennan P; Wünsch-Filho V
Cancer Causes Control; 2014 Apr; 25(4):461-71. PubMed ID: 24474236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
